Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.72
+0.10 (1.04%)
At close: Mar 23, 2026, 4:00 PM EDT
9.83
+0.11 (1.13%)
After-hours: Mar 23, 2026, 7:59 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 9 analysts that cover Novavax stock have a consensus rating of "Hold" and an average price target of $11.33, which forecasts a 16.56% increase in the stock price over the next year. The lowest target is $6.00 and the highest is $19.
Price Target: $11.33 (+16.56%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Novavax stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 2 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $11 → $16 | Strong Buy | Maintains | $11 → $16 | +64.61% | Feb 27, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +95.47% | Jan 20, 2026 |
| JP Morgan | JP Morgan | Sell Maintains $7 → $6 | Sell | Maintains | $7 → $6 | -38.27% | Nov 18, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $18 → $16 | Strong Buy | Reiterates | $18 → $16 | +64.61% | Nov 10, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $7 | Hold | Maintains | $8 → $7 | -27.98% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
407.83M
from 1.12B
Decreased by -63.70%
Revenue Next Year
277.59M
from 407.83M
Decreased by -31.93%
EPS This Year
-0.36
from 2.58
EPS Next Year
-0.25
from -0.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 557.0M | 454.6M | |||
| Avg | 407.8M | 277.6M | |||
| Low | 245.5M | 107.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -50.4% | 11.5% | |||
| Avg | -63.7% | -31.9% | |||
| Low | -78.1% | -73.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 0.79 | 0.83 | |||
| Avg | -0.36 | -0.25 | |||
| Low | -1.31 | -1.16 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -69.4% | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.